Search - tctmd.com

Displaying 21 - 40 of 352

Sort: Relevancy | Date

News Daily News

Current or Prior Cancers Affect PCI Outcomes Differently, Large Analysis Shows

L.A. McKeown

December 04, 2018

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

News Daily News

US and European DAPT Guidelines More Alike Than Different, Say Experts

Yael L. Maxwell

December 03, 2018

News Daily News

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

L.A. McKeown

November 27, 2018

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Daily News

Female Cardiologists and Interventionalists Rare, Isolated in Australia and New Zealand

Shelley Wood

November 22, 2018

News Daily News

Bullying or Violence on the Job May Boost CVD Risk

Todd Neale

November 22, 2018

News Daily News

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Caitlin E. Cox

November 21, 2018

News Daily News

Treating to New Blood Pressure Goals Could Prevent Millions of CVD Events

L.A. McKeown

November 21, 2018

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

News Daily News

Frailty Linked to Higher Bleeding Risk Among Acute MI Patients Undergoing PCI

L.A. McKeown

November 19, 2018

News Daily News

FDA Allows Claim About Oleic Acid’s Possible Heart Benefits on Labeling

Todd Neale

November 19, 2018

News Conference News AHA 2018

Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest

Yael L. Maxwell

November 16, 2018

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Daily News

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Caitlin E. Cox

November 15, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News AHA 2018

AHA Puts Focus on the Impact of Violence on Cardiovascular Health

Todd Neale

November 14, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Daily News

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Yael L. Maxwell

November 14, 2018

Advertisement

Current or Prior Cancers Affect PCI Outcomes Differently, Large Analysis Shows

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

US and European DAPT Guidelines More Alike Than Different, Say Experts

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Female Cardiologists and Interventionalists Rare, Isolated in Australia and New Zealand

Bullying or Violence on the Job May Boost CVD Risk

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Treating to New Blood Pressure Goals Could Prevent Millions of CVD Events

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Frailty Linked to Higher Bleeding Risk Among Acute MI Patients Undergoing PCI

FDA Allows Claim About Oleic Acid’s Possible Heart Benefits on Labeling

Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

AHA Puts Focus on the Impact of Violence on Cardiovascular Health

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content